Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03647085 · ClinicalTrials.gov registry record
Data Collection Atrial Fibrillation Exploratory Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 27
- Enrollment target
NCT03647085 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 27 participants.
The verdict
NCT03647085 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
To characterize the impact of Atrial fibrillation (AFib) and Atrial Flutter (AFl) on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of AFib/AFl symptom severity with various physiologic signals measured from the wearable cardiac monitor prototype device.
Interventions
- DEVICE Wearable cardiac monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2019-01-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03647085
The ClinicalTrials.gov registry entry for NCT03647085 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wearable cardiac monitor is the first listed.
NCT03647085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03647085 about?
NCT03647085 is a clinical study titled "Data Collection Atrial Fibrillation Exploratory Study". To characterize the impact of Atrial fibrillation (AFib) and Atrial Flutter (AFl) on signals measured using a wearable cardiac monitor prototype device. To evaluate the relationship of AFib/AFl symptom severity with various physiologic signals measured from the wearable cardiac monitor prototype de...
What is the current status of trial NCT03647085?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2018-08-29. Estimated completion is 2019-01-10.
What interventions are being tested in trial NCT03647085?
The interventions under investigation include: Wearable cardiac monitor (DEVICE).
Who is sponsoring clinical trial NCT03647085?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.